Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Arroyo v. Chattem, Inc.
Case Number:
3:12-cv-02129
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
November 06, 2012
Dexatrim Maker Beats Suit Alleging Pills Are Unsafe
A California federal judge tossed a putative class action Tuesday accusing Chattem Inc. of concealing a dangerous chemical in its Dexatrim weight loss supplements, finding the suit was not specific enough about the product's danger or consumers' reliance on Chattem's alleged omissions when buying it.
-
May 23, 2012
Dexatrim Maker Says Suit Doesn't Show Harm From Carcinogen
Drugmaker Chattem Inc. asked a California federal judge Monday to toss a proposed class action accusing it of concealing the presence of a carcinogen in its Dexatrim weight loss capsules, saying the consumer doesn’t argue she was harmed by the supplement.
-
May 01, 2012
Chattem Concealed Carcinogen In Dexatrim, Suit Says
Drugmaker Chattem Inc. was struck with a putative class action Friday in California federal court accusing the company of falsely marketing its over-the-counter Dexatrim-brand weight loss pills as safe and effective while actively concealing a cancer-causing chemical ingredient.